$CervoMed (CRVO.US)$Reuters· 2 mins ago CervoMed Announces Orphan Drug Designation Granted to Neflamapimod by U.S. Food and Drug Administration for the Treatment of Frontotemporal Dementia
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more